Long Term Safety Study of Plecanatide

NCT02706483 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2272

Enrollment

INDUSTRY

Sponsor class

Conditions

Irritable Bowel Syndrome

Interventions

DRUG: Plecanatide

Sponsor

Bausch Health Americas, Inc.